Defunct Company
Total Trials
5
As Lead Sponsor
2
As Collaborator
3
Total Enrollment
1,094
NCT01719783
Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine
Phase: Phase 1
Role: Collaborator
Start: Sep 30, 2012
Completion: Jan 31, 2013
NCT03235765
Cancer Panel From Blood of Lung Cancer Patients
Phase: N/A
Start: Mar 10, 2017
Completion: Mar 10, 2020
NCT04404855
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
Start: Dec 18, 2019
Completion: Aug 31, 2022
NCT04842435
Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
Phase: Phase 2/3
Role: Lead Sponsor
Start: Apr 12, 2021
Completion: Oct 5, 2021
NCT05012072
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
Start: Aug 1, 2021
Completion: Apr 13, 2026